Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1897
  • Home
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2012  |  Volume : 60  |  Issue : 2  |  Page : 87-93

Thyroid associated orbitopathy


1 Department of Ophthalmology, Royal Alexendra Hospital, University of Alberta, Edmonton, Alberta, Canada T5H 3V9; Orbit, Oculoplasty and Ocular Oncology, Netraseva Eye Associates, Jalna, Maharashtra, India
2 Department of Ophthalmology, Royal Alexendra Hospital, University of Alberta, Edmonton, Alberta, Canada T5H 3V9

Correspondence Address:
Rajat Maheshwari
Orbit, Oculoplasty and Ocular Oncology, Netraseva Eye Associates, Jalna 431 203, Maharashtra

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0301-4738.94048

Rights and Permissions

Thyroid associated orbitopathy, also known as Graves' orbitopathy, is typically a self-limiting autoimmune process associated with dysthyroid states. The clinical presentation may vary from very mild disease to severe irreversible sight-threatening complications. Despite ongoing basic science and clinical research, the pathogenesis and highly effective therapeutic strategies remain elusive. The present article reviews the pathophysiology, clinical presentation, and management of this common, yet poorly understood disease, which remains a challenge to the ophthalmologist.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed11428    
    Printed154    
    Emailed16    
    PDF Downloaded1519    
    Comments [Add]    
    Cited by others 8    

Recommend this journal